METHODS FOR DIAGNOSIS, DIFFERENTIATION AND MONITORING USING URINE PROTEINS AS MARKERS IN IGA NEPHROPATHY

METHODS FOR DIAGNOSIS, DIFFERENTIATION AND MONITORING USING URINE PROTEINS AS MARKERS IN IGA NEPHROPATHY

The present invention relates to use of markers selected from a group consisting of alpha- IB -glycoprotein (A1BG), alpha-l-acid glycoprotein 1 (ORM1), Ig lambda-2 chain C regions (IGLC2) and serotransferrin (TF) in methods for diagnosis, monitoring and differentiation of IgA nephropathy. In additio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PIWOWARSKI, Jan, GRZESIUK, Elzbieta, ZAGOZDZON, Radoslaw, DADLEZ, Michal, FLORCZAK, Michal, PACZEK, Leszek, MARCINKOWSKI, Michal, MUCHA, Krzysztof, FORONCEWICZ, Bartosz, BAKUN, Magdalena, GARBICZ, Damian, PILZYS, Tomas
Format: Patent
Sprache:eng ; fre
Schlagworte:
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to use of markers selected from a group consisting of alpha- IB -glycoprotein (A1BG), alpha-l-acid glycoprotein 1 (ORM1), Ig lambda-2 chain C regions (IGLC2) and serotransferrin (TF) in methods for diagnosis, monitoring and differentiation of IgA nephropathy. In addition corresponding diagnostic kits are provided. La présente invention concerne l'utilisation de marqueurs sélectionnés dans un groupe constitué de l'α-1B-glycoprotéine (A1BG), l'α-1-acide glycoprotéine (ORM1), des régions C de la chaîne d'IgG lambda-2 (IGLC2) et de la sérotransferrine (TF) dans des procédés de diagnostic, de surveillance et de différenciation de la néphropathie à IgA. L'invention concerne également des kits de diagnostic correspondants.